| Bioactivity | Anticancer agent 223 (Compound V-d) is an anticancer agent that triggers cell death through caspase-dependent and caspase-independent mechanisms. Anticancer agent 223 inhibits tumor spheroid formation and resensitizes cisplatin (HY-17394)-resistant A2780 cells to cisplatin (HY-17394) treatment[1]. |
| CAS | 1328150-75-9 |
| Formula | C20H19ClN4O |
| Molar Mass | 366.84 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Thuy Lu Vo T, et al. Design, synthesis and biological evaluation of novel quinazoline derivatives as immune checkpoint inhibitors. Bioorg Med Chem Lett. Published online May 15, 2024. |
Anticancer agent 223
CAS: 1328150-75-9 F: C20H19ClN4O W: 366.84
Anticancer agent 223 (Compound V-d) is an anticancer agent that triggers cell death through caspase-dependent and caspas
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.